|
|
South Florida Ancure Abdominal Heart Stent Lawyer, Florida Ancure Abdominal Heart Stent AttorneysSouth Florida Ancure abdominal heart stent lawyer David I. Fuchs has over 17 years of experience in successfully product liability victims, their families and friends who have sustained and suffered serious bodily injuries and health problems because of the negligence of the manufacturer of a medical or other device. The Ancure abdominal heart stent was first approved by the FDA in 1999 for the treatment of a common and often fatal condition called abdominal aortic aneurysm (AAA). This condition causes a weakness in the artery carrying blood from the heart through the abdomen to the rest of the body. The Ancure abdominal heart stent was designed to hold up these arteries to prevent AAA complications. The procedure used to insert this medical device is much less invasive than traditional techniques. For this reason, the Ancure abdominal heart stent has been used in thousand of AAA patients. The makers of the Ancure abdominal heart stent, Guidant Corporation, recently pled guilty to ten felony counts of making false statements to the FDA about the safety and efficacy of this medical device and fraudulently shipping misbranded medical devices. During the first two years this devise was used, twelve people died, 57 required open heart surgery, and hundreds needed open intra-abdominal surgeries as a result of serious injuries caused by Ancure abdominal heart stent complications. Over 7,600 patients received Ancure abdominal heart stent implants between September 1999 and March 2001. The FDA now has record of over 2,628 cases of serious Ancure abdominal heart stent malfunctions resulting in serious injury or complications. These reports were made to Guidant years earlier but the company intentionally concealed these findings from the public and the government. Guidant knew about the many defects and complications that could occur with the Ancure abdominal heart stent. Physicians often reported serious complications with implantation of the Ancure abdominal heart stent. On hundreds of occasions, untrained Guidant salespeople would actually instruct surgeons about how to deal with medical complications during an operation. The most common complication was the inability to remove the catheter from the patient’s body. Guidant employees even developed what came to be known as the “handle-breaking technique” whereby a surgeon would actually have to break the Ancure instruments apart to remove the catheter from a patient’s body. This was rarely successful and often led to serious injuries, including paralysis and death. In June 2003, the United States Attorney filed suit against Guidant, on behalf of the FDA for these grossly intentional civil and criminal acts. The company was fined $92.4 million after pleading guilty on more than a dozen civil and criminal counts. Numerous lawsuits have also been filed by the victims of this nightmarish ordeal: the patients who suffered serious injury, illness, and even death as a result of Ancure abdominal heart stent defects and manufacturer misdeeds. The FDA now has information about 75 cases of death and 991 injuries related to Ancure abdominal heart stent complications. The Ancure abdominal heart stent was first approved by the FDA in 1999 for the treatment of a common and often fatal condition called abdominal aortic aneurysm (AAA). This condition causes a weakness in the artery carrying blood from the heart through the abdomen to the rest of the body. The Ancure abdominal heart stent was designed to hold up these arteries to prevent AAA complications. The procedure used to insert this medical device is much less invasive than traditional techniques. For this reason, the Ancure abdominal heart stent has been used in thousand of AAA patients. The makers of the Ancure abdominal heart stent, Guidant Corporation, recently pled guilty to ten felony counts of making false statements to the FDA about the safety and efficacy of this medical device and fraudulently shipping misbranded medical devices. During the first two years this devise was used, twelve people died, 57 required open heart surgery, and hundreds needed open intra-abdominal surgeries as a result of serious injuries caused by Ancure abdominal heart stent complications. Over 7,600 patients received Ancure abdominal heart stent implants between September 1999 and March 2001. The FDA now has record of over 2,628 cases of serious Ancure abdominal heart stent malfunctions resulting in serious injury or complications. These reports were made to Guidant years earlier but the company intentionally concealed these findings from the public and the government. Guidant knew about the many defects and complications that could occur with the Ancure abdominal heart stent. Physicians often reported serious complications with implantation of the Ancure abdominal heart stent. On hundreds of occasions, untrained Guidant salespeople would actually instruct surgeons about how to deal with medical complications during an operation. The most common complication was the inability to remove the catheter from the patient’s body. Guidant employees even developed what came to be known as the “handle-breaking technique” whereby a surgeon would actually have to break the Ancure instruments apart to remove the catheter from a patient’s body. This was rarely successful and often led to serious injuries, including paralysis and death. In June 2003, the United States Attorney filed suit against Guidant, on behalf of the FDA for these grossly intentional civil and criminal acts. The company was fined $92.4 million after pleading guilty on more than a dozen civil and criminal counts. Numerous lawsuits have also been filed by the victims of this nightmarish ordeal: the patients who suffered serious injury, illness, and even death as a result of Ancure abdominal heart stent defects and manufacturer misdeeds. The FDA now has information about 75 cases of death and 991 injuries related to Ancure abdominal heart stent complications. South Florida Ancure abdominal heart stent lawyer David I. Fuchs will also represent you in other personal injury matters for injuries that include, but are not limited to:
If you have had an Ancure abdominal heart stent implant, it is then important to seek legal counsel to protect your legal rights by calling Florida Ancure abdominal heart stent lawyer David I. Fuchs who will take your call and speak with you immediately about your Ancure abdominal heart stent case. Florida Ancure abdominal heart stent lawyer David I. Fuchs will then stand ready to fight for you to see that you get compensation for your pain and suffering, any lost wages and medical bills. Call South Florida Ancure abdominal heart stent attorney David I. Fuchs Toll Free at 800-570-2858 for a free consultation to discuss your Ancure abdominal heart stent case. You may also write to Florida Ancure abdominal heart stent attorney David I. Fuchs by filling out the form on the "Contact Us" page." If you can not come to us South Florida Ancure abdominal heart stent lawyer David I. Fuchs will send a representative to see you. We speak English and Spanish. Se habla ingles y espanol. Llame David Fuchs Florida Ancure el abogado de stent de corazón abdominal.. |